|
|
|
W. Gerald Newmin, Chairman of the Board, CFO and
Acting President and CEO
Mr. W.
Gerald Newmin joined the Company in June 1995.
He currently serves as chairman of the Board of Directors and secretary.
Mr. Newmin is chairman, CEO, secretary, and a
director of Xenogenics Corporation, a
majority-owned subsidiary of the Company; chairman, CEO, secretary, and
director of MCT Rhode Island Corp., a wholly-owned subsidiary of the Company;
and CEO, secretary, and a director of MultiCell
Immunotherapeutics, Inc. (MCTI), a
majority-owned subsidiary of the Company. He serves on the Board of
Directors of San Diego Defcomm, a
not-for-profit consortium of defense companies based in San Diego. Mr. Newmin
has a bachelor’s degree in accounting from Michigan State University.
|
